(Burness) TB Alliance's new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has been accepted for review by the United States Food and Drug Administration (FDA).
from EurekAlert! - Social and Behavioral Science https://ift.tt/2NNmMts
No comments:
Post a Comment